Skip to jobs
Unlisted
All jobs

Replimune · Quality, Manufacturing, Technical Operations

Associate Director, Facilities and Engineering

Where
Milton Park
Experience
10+ yrsguessed from the title
Pay
Not stated
Posted
Already listed when Unlisted started watching this board (6 Oct 2026)
Apply on AshbyOpens the employer's own posting

Checking Ashby for this posting…

Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal.

Audacious: We Are Bold.

Dedicated: We Give Our Full Commitment.

Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description:

The Associate Director, Facilities and Engineering is responsible for the routine management of the Facilities Department at the Milton Park site. The Facilities Department is responsible for ensuring all equipment and utilities are operating as required to support domestic, cGMP and general laboratory operations. The Department manages all building systems (e.g., Monitoring systems, security, alarms and HVAC), coordinates further third party / remote support e.g., Site cleaning, I.T, telephone, data management.

This position is based in our Milton Park location and typically has a 5-day on-site expectation.

Key responsibilities:

Other responsibilities

Educational requirements:

Experience and skill requirement:

About Replimune


Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

We are an Equal Opportunity Employer.